Expand BNTX Menu
BNTX MENU

BNTX Latest Press Releases

-- June 3, 2026 --

The Multi-Billion-Dollar Search for Better Glioblastoma Treatments Globe Newswire 9:28 AM

-- May 30, 2026 --

Global Data for BioNTech and Bristol Myers Squibb's PD-L1xVEGF-A Bispecific Pumitamig Shows Encouraging Efficacy in Patients with Non-Small Cell Lung Cancer in ROSETTA Lung-02 Trial Globe Newswire 2:15 PM

-- May 22, 2026 --

BioNTech to Showcase Progress Across Late-Stage Oncology Pipeline at the 2026 ASCO Annual Meeting Globe Newswire 5:00 AM

-- May 15, 2026 --

BioNTech SE Shareholders Approve All Agenda Items at the Annual General Meeting 2026 Globe Newswire 4:15 PM

-- May 7, 2026 --

BioNTech Announces New ADS Repurchase Program Globe Newswire 6:45 AM

-- May 5, 2026 --

BioNTech Announces First Quarter 2026 Financial Results and Corporate Update Globe Newswire 6:45 AM

-- April 21, 2026 --

BioNTech to Report First Quarter 2026 Financial Results and Corporate Update on May 5, 2026 Globe Newswire 6:45 AM

-- April 11, 2026 --

BioNTech and DualityBio's Antibody-Drug Conjugate Trastuzumab Pamirtecan Demonstrated Clinically Meaningful Efficacy in Patients with HER2-Expressing, Recurrent Endometrial Cancer Globe Newswire 7:00 AM

-- March 24, 2026 --

BioNTech Clinical Data at ELCC 2026 Highlight Potential of Differentiated Late-Stage Portfolio in Lung Cancer Globe Newswire 6:45 AM

-- March 10, 2026 --

BioNTech SE Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses Globe Newswire 2:48 PM
BioNTech Announces Fourth Quarter and Full Year 2025 Financial Results and Corporate Update Globe Newswire 6:45 AM
BioNTech and Co-Founders Announce Plan to Pursue Next-Generation mRNA Innovations in Co-Founders-Led New Company as BioNTech Advances Toward Becoming a Multi-Product Company by 2030 Globe Newswire 6:33 AM

-- February 24, 2026 --

BioNTech to Report Fourth Quarter and Full Year 2025 Financial Results and Corporate Update on March 10, 2026 Globe Newswire 6:45 AM

-- January 28, 2026 --

BioNTech Announces Appointment of Kylie Jimenez to Management Board as Chief People Officer Globe Newswire 8:00 AM

-- January 14, 2026 --

The $185B Cancer Surge: Why the FDA's Fast-Track Pivot is Scaling a New Immunotherapy Era Globe Newswire 10:40 AM

-- January 12, 2026 --

BioNTech Provides Strategic Business Update and Outlines 2026 Areas of Focus at 44th Annual J.P. Morgan Healthcare Conference Globe Newswire 6:45 AM
Market Data Delayed 15 Minutes